Our web site is currently under creative and inspirational construction. 

Going live soon.  In the meantime.......

  We produce plant-made proteins. 

Cheaper.  Faster.  Safer.  Better.

Cape Bio Pharms is a new and exciting initiative to commercialise the biotechnology developed by the Bio Pharming Research Unit of the University of Cape Town.  In short, we aim to grow proteins in tobacco.  The plant-based platform is a  disruptive protein expression technology that has established its effectiveness globally.   Our product pipeline is exclusive and patent protected and a first for South Africa and the African continent.
_____________ 
Our aim is to develop a world class commercial-scale platform in South Africa for the production of patented plant-produced proteins for the pharmaceutical and industrial industries.  Biopharming now provides enormous opportunities for both the agricultural sector and the bio-technology business sector at the same time.
_____________ 
This venture answers to the South African Government's Strategy to develop a vibrant Bio-Economy which aims to "amalgamate our experience, expertise and competitive advantages to create a world-class biotechnological system of innovation"
_____________ 
  Traditional protein production systems such as microbial fermentation , insect and mammalian cell cultures, bacteria, yeast or egg cultures are beyond the reach of countries like South Africa.  They are extremely expensive systems to build, costing anything between $250m to $450m to build and can take four to five years to come online. Proteins or vaccines produced this way are also very expensive, can take months to produce and have limited ability for rapid scale up.  They may also contain animal pathogens , for example people that are allergic to eggs may have an allergic reaction to flu vaccines, yellow fever or MMR.  
_____________ 
Our plant-based expression platform costs a 10th of the price, will be up and running in a matter of months and can produce quality proteins at a fraction of the cost and is infinitely scaleable - we just grow more plants.  Our proteins do not involve animals in any way and are therefore safer (no plant pathogen can jump across to humans) An exciting aspect of the plant-based platform in terms of new drug discover is that, unlike traditional systems,  plants can produce complex proteins on their own.  
_____________ 
 The production of plant-based biologics has a scientifically proven track record globally.  There are now a host of successful products on the international market that have been produced in plants such as ZMapp - the ebola trial vaccine, Humira - a treatment for rheumatoid arthritis which has become the world's leading prescription drug . Plant-made pharmaceuticals now include therapeutic proteins, antibodies and vaccines, industrial enzymes, technical proteins, milk proteins and protein polymers.  Plant-based protein manufacture is faster - a new protein can be expressed and purified in weeks;   it's cheaper - costs a tenth of the price and is far safer -  plant pathogenic organisms cannot cause human disease, unlike the risks faced with mammalian cells.
_____________ 
Together with our experienced partners we passionately believe that by unlocking and successfully commercializing the vast intellectual property developed by the BioPharming Research Unit we can secure South Africa's position in the global biopharming market.  
It is an initiative that also has, at its heart, the creation of exciting new job opportunities in biotechnology and the development of critical skills for our young bio-scientists, bio-technologists and budding agro-scientists.
_____________ 

E-mail us or talk to us if you are interested in finding out more.

_____________ 

Cape Bio Pharms (Pty) Ltd